Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869479 · ClinicalTrials.gov registry record
Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 60
- Enrollment target
NCT00869479: Completed study, sponsored by Massachusetts General Hospital.
NCT00869479 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00869479 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The Primary Aim of this study is to validate a questionnaire as a screening tool to identify subjects with symptoms suggestive of nephrogenic systemic fibrosis (NSF). The investigators believe that there will be difference between subjects with NSF and other skin conditions and normal skin.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00869479
The ClinicalTrials.gov registry entry for NCT00869479 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00869479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00869479 about?
NCT00869479 is a clinical study titled "Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis". The Primary Aim of this study is to validate a questionnaire as a screening tool to identify subjects with symptoms suggestive of nephrogenic systemic fibrosis (NSF). The investigators believe that there will be difference between subjects with NSF and other skin conditions and normal skin.
What is the current status of trial NCT00869479?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2009-03. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT00869479?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.